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The Diagnosis of Periodontal Disease
in Private Practice
D.J. Apsey,* N. Kaciroti,† and W.J. Loesche‡
Background: Periodontal disease is an inflammatory reac-
tion to the bacteria in dental plaque. The present study com-
pared the prevalence of periodontal disease in patients using
as a diagnostic either probing depth measurements, an in-
flammatory marker such as numbers of white blood cells in
plaque samples, or microbiological markers such as the mi-
croscopic count and the benzoyl-DL-arginine naphthylamide
(BANA) test.
Methods: Teeth with the most inflammation and/or deepest
pockets in each quadrant were probed and subgingival plaque
was sampled from 1,043 consecutive new patients enrolled
in a private practice. Multivariate ‘‘diagnostic’’ models were
developed based upon the probing depth (general linear
models), percentage of white blood cell–positive and percent-
age of BANA-positive plaques (logistic regression models) to
determine the prevalence of patients with periodontal disease.
Results: Plaque samples were removed from 3,694 sites.
Fifty-two percent of sampled pockets were >4 mm; 49% of
sites were inflamed, using the presence of white blood cells,
and 28% were infected using the BANA test. Diagnostic
models were highly significant at P <0.0001. The white blood
cell model was the most parsimonious as demonstrated by
the lowest Akaike information criteria statistic and had the
highest receiver operator characteristic (ROC) curve relative
to the probing depth and BANA models.
Conclusions: Periodontal disease can be diagnosed chair-
side by the presence of white blood cells in plaque samples,
a finding that reflects the inflammatory nature of the disease
process. This approach would reduce the misclassification of
subjects as having periodontal disease (130 patients in the
present study who had pockets) but minimal evidence of an
inflammatory response. J Periodontol 2006;77:1572-1581.
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P
eriodontal disease is a common
affliction of adults with about 50%
having gingivitis and 30% having
periodontitis.1-3 Most forms reflect a
tissue inflammatory response to bacte-
rial accumulations on the teeth. These
accumulations represent an overgrowth
of a finite number of bacterial species,
mostly anaerobes, in the subgingival
dental plaque, thereby making peri-
odontal disease a chronic but specific
bacterial infection.4 The American
Academy of Periodontology5 states that
‘‘Periodontal (gum) diseases, including
gingivitis and periodontitis, are serious
infections that, left untreated, can lead
to tooth loss.’’ Most periodontology text-
books define periodontal disease as an
inflammatory reaction to a microbial
infection associated with dental plaque
that results in tissue loss.6,7 For many
patients, the clinical recognition of peri-
odontal disease is made by probing
measurements about the teeth and by
radiographs, which document the
amount of tissue support that has been
lost about the tooth. Bleeding on prob-
ing is commonly found in periodontal
disease but has a low sensitivity as a
predictor of periodontal disease pro-
gression because of a high frequency
of false-positive (FP) responses.8
The absence of microbiological diag-
nostic criteria in clinical periodontics has
some practical basis as the culturing of
plaque samples for anaerobes is fraught
with technical problems and results can
take weeks to be determined. Likewise,
the taking of blood or gingival samples
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que samples, which, since Leuwenhoek in the 16th
century, have shown the abundance of motile orga-
nisms, such as spirochetes, in samples removed from
disease sites.9,10 Keyes and Rams11 demonstrated
that the microscopic examination of plaque samples
could be used to adjust the treatment regimens for in-
dividual patients by monitoring the numbers of white
blood cells (WBCs) and motile organisms. Successful
treatment(s) resulted in a disappearance of WBCs and
a reduction in motile organisms associated with an in-
crease in cocci and rods.
Bacteriological studies have consistently shown
the dominance of a limited number of anaerobic spe-
cies such as Treponema denticola, Porphyromonas
gingivalis, and Tannerella forsythensis in plaques re-
moved from disease sites.4,12,13 These organisms
are difficult to culture but can be detected using a
laboratory-based DNA technique.14 They are unique
among cultivable plaque species in possessing one
ormoreenzymesthatcanhydrolyze thesynthetic tryp-
sin substrate, benzoyl-DL-arginine naphthylamide
(BANA).15 This enzyme(s) can be detected in plaque
samples within minutes at chairside with a sensitivity
and specificity comparable to DNA probes.16,17
The purpose of the present study was to compare
the prevalence of periodontal disease in patients seen
in a private practice using either probing depth mea-
surements or an inflammatory marker such as num-
bers of WBCs in plaque samples or microbiological
markers such as the microscopic count and the BANA
test. To our knowledge, no one has used all three ap-
proaches simultaneously in the same subjects. The
findings obtained on 1,043 subjects permitted multi-
variate modeling to determine which of these diagnos-




Data were obtained from 1,043 consecutive new den-
tal patients enrolled between April 1997 and Novem-
ber 2001 at a private practice located in southeast
Michigan. The practice was unusual in that it adver-
tised an offering of non-surgical periodontal therapy,
so that the patient profile was enriched by patients
seeking periodontal treatment. Patients were told that
most forms of periodontal disease are treatable infec-
tions and that microbiological criteria, such as a mi-
croscopic examination of plaque samples and an
enzyme assay for plaque bacteria, would be routinely
performed to assist in the diagnosis and monitoring of
treatment results in addition to the traditional pocket
probing measurements. All adults were screened on
their first visit. They were aware that data from their
examination would be used in a research study and
that no person would be identified in any publication.
Only patients who agreed that their data could be used
were included in the analysis. The procedures en-
dorsed by the Helsinki Declaration were followed.
The personal identifiers of the patients were rendered
in a cryptic form in the file used in the statistical anal-
ysis and were never accessed.
Selection of Teeth and Sampling Procedures
Teeth with the most inflammation (tissue swelling,
bleeding, and suppuration) and/or deepest pockets
in each quadrant were probed, and subgingival
plaque was removed and sampled for microscopic
and enzyme markers. As some patients had no obvi-
ous clinical disease, this meant that periodontally
healthy teeth and diseased teeth were sampled. The
probing depth(s) and gingival recession of selected
teeth were determined using a Michigan-type probe.
A subgingival plaque sample was obtained with a Co-
lumbia 13/14 curet from an interproximal site on a
tooth. Approximately half of this sample was added
to a drop of saline on a microscopic slide, and the re-
mainder was applied to the lower reagent matrix of the
BANA test. About 10 to 20 seconds after the sample
was collected, the papillary bleeding score (PBS) was
measured.18
Microscopic Examination
Microscopic samples were read immediately using
400· magnification on a phase-contrast micro-
scope.§ From one to five microscopic fields were ex-
amined on each sample for the presence of WBCs,
motile organisms (spirochetes, spinning rods, motile
cocci, and gliding rods), cocci, spiral rods, amoeba,
and trichomonads. Levels of each microscopic cate-
gory were scored as follows: 0 = not present in any
of the five microscopic fields; 1 = few present in one
or more fields; 2 = present in every field in moderate
numbers; and 3 = present in high numbers.11 For
the statistical analysis, each site was scored either
as a 0 (no infection; microscopic score of 0 or 1) or
1 (infection; microscopic score of 2 or 3) for each
morphotype.
BANA Test
The plaque on the scaler was wiped onto the BANA-
impregnated strip found at the bottom of a reagent
card.i The upper reagent strip was activated by lightly
moistening it with distilled water. The two strips were
folded to contact each other, and the card was inserted
into a heating block and incubated for 5 minutes at
55C.15 Naphthylamide released due to the presence
of BANA-hydrolyzing bacterial species diffused into
§ Meiji Microscope, Oratec, Manassas, VA.
i Oratec.
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the upper reagent strip where it reacted with a dye to
form a permanent blue color. A score of 1 was given
when no blue color was visible, a score of 2 when a
faint blue color was noted, and a score of 3 when a dis-
tinct blue color was observed. For statistical analysis,
scores of 2 and 3 were grouped as indicative of a pos-
itive response. Each site was then scored either as a 0
(no infection; BANA score of 1) or 1 (infection; BANA
score of 2 or 3).
PBS
The amount of bleeding present was scored using the
PBS,18 a six-level scale with a score of 0 reflecting
health, 1 indicating some degree of inflammation in
the absence of bleeding, 2 indicating spotting of blood
in the papilla, and PBS from 3 to 5 corresponding to
various degrees of bleeding. The same investigator
(DJA) collected all plaque samples and judged each
PBS.
Statistical Analysis
The data were entered in a spreadsheet program,¶ and
batch-transferred to statistical software.# Data for the
sampled teeth were averaged so that only per patient
values were used in the statistical analysis. For the mi-
croscopic and BANA data, both average values and
percentage of infected sites were used, i.e., percent-
age of sites with a 1 (infected) score for the variable
under consideration. Descriptive statistics, correla-
tions, and x2 frequency distributions were determined
for variables of interest. The following models were
developed: three general linear models with probing
depths ‡4, ‡5, and ‡6 mm as the primary outcome
and four multiple logistic regression models in which
the presence of an infection was determined by the
number of subjects with >0% of sites showing an infec-
tion with WBCs; >50% of sites showing an infection
with WBCs; >0% of sites showing an infection with a
BANA-positive score; and >50% of sites showing an
infection with BANA-positive sites. The predictor var-
iables were age, gender, smoking status (never, quit,
and current), PBS, gingival recession, microscopic
morphotypes, and, where appropriate, probing depth,
BANA score, and WBC score. Receiver operating
characteristic (ROC) curves (Fig. 1), a global assess-
ment of explanatory ability created by plotting sensi-
tivity by 1-specificity, were constructed for the various
models using probing depth first and then the percent-
age of WBCs or percentage of BANA as the diagnostic
criterion. This provided an estimate of the correct
identification of treatment needs versus FP identifica-
tion for each of the diagnostic criteria.
RESULTS
The participants were 53% male, averaged 46.9 years
of age, and 23% were current smokers, 17% were for-
mer smokers, and 60% had never smoked. Plaque
samples were removed from between two and eight
sites per patient (72% provided four sites) for a total
of 3,694 sites. The selection of sites was based on clin-
ical inflammation and emphasized molars (N = 2,534
sites; 68.6%) over bicuspids (N = 701 sites; 19.0%)
and anterior teeth (N = 459 sites; 12.4%). The average
probing depth was 4.6 mm, and 52% of the sampled
pockets were >4 mm. Forty-nine percent of the sam-
pled sites were inflamed, using the presence of WBCs
as the diagnostic criteria, and 28% were infected with
anaerobic species using the BANA test (Table 1).
The current and former smokers were combined as
an ever-smoked group and compared to the never-
smoked group (Table 1). Smokers were significantly
younger (45.0 versus 48.2 years). Pockets were 0.6
mm deeper, and attachment loss was 0.9 mm greater
(P <0.001) in smokers compared to non-smokers.
Sixty-five percent of the sampled pockets were >4
mm in the smokers compared to 46% in the never-
smoked group. Smokers had significantly higher per-
centages of sites that were WBC and BANA positive
and were significantly more likely to score positive
on most microbiological parameters, i.e., spirochetes
(35% versus 21.6%), small gliding rods (34% versus
24%), and spinning rods (48% versus 38%) (Table 1).
Patients are usually diagnosed as having peri-
odontal disease based upon measurements of prob-
ing depth. We were interested in how many and
what types of individuals would be diagnosed if crite-
ria indicative of an inflammatory or infectious process
were used, i.e., the percentages of tooth sites that
were WBC positive or which were overgrown with
the BANA species. In this regard, we applied relaxed
and stringent thresholds of diagnostic criteria and, as
expected, observed more patients diagnosed when
Figure 1.
ROC curves for WBC, probing depth, and BANA models.
¶ Excel, Microsoft, Redmond, WA.
# SAS version 8.2, SAS Institute, Cary, NC.
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thresholds were set low. When we used the presence
of sites with probing depths ‡4 mm (relaxed) as the
threshold, 78% of subjects would have been diag-
nosed as having periodontal disease (Table 2). When
ahigher (stringent) levelwasused, i.e., probingdepths
‡6 mm, 31% of subjects would have been recom-
mended for treatment. When ‡5 mm was used, as is
common in clinical practice, 52% of the patients
would have been diagnosed with periodontal disease.
Sixty-five percent of the subjects would have been
diagnosed with periodontal disease if the presence of
any site positive for WBCs was used (relaxed) com-
pared to 54% if subjects had to have >50% of sites that
were WBC positive (stringent) (Table 2). For the
BANA test, the respective values were 43% (relaxed)
and 24% (stringent). The stringent WBC model (N =
563) and the standard probing depth model (N =
540) were the most similar in the number of patients
identified as having periodontal disease. The least
number of patients was identified by the stringent
BANA model (N = 252) and the stringent probing
depth model (N = 318).
We conducted a series of x2 analyses in which all
possible combinations of thresholds for probing
depth, percentage of WBC-positive sites, and per-
centage of BANA-positive sites were compared to
each other (Table 3). All comparisons were highly
significant (P <0.001), indicating that the various
diagnostic criteria were mostly identifying the same
patients. The Cohen statistic, which provides the k co-
efficient of agreement between the various diagnostic
criteria, had the highest value, i.e., 0.47, when £4
versus ‡5 mm probing depth (reference standard)
were compared to £50% of sites that were WBC
positive versus >50% of sites that were WBC posi-
tive (test), indicating that this was the best of the
comparisons.
If this comparison is examined in detail (Table 4),
when probing depth is used as the reference standard
andWBCsareusedasthe test, theaccuracywas73.8%
(true positive [TP] + true negative [TN]/sample size ·
100), the sensitivity (TP/TP + false negative [FN])
was 76.4%, the specificity (TN/TN + FP) was 71%,
the positive-predictive value (TP/TP + FP) was
Table 1.
Demographic, Clinical, and Microbiological Characteristics of Patients Enrolled in the
Study and Differences Between Smokers and Non-Smokers
Total (N = 1,043)
(mean – SD)
Ever (current and quit)
Smoked (n = 414)
Never Smoked
(n = 629)
Probability (t test): Ever Versus
Never Smoked
Demographics
Age (years) (mean – SD) 46.9 – 13.6 45.3 – 11.5 48.0 – 14.7 0.0015
Gender (% male) 53.7 50 – 50 56 – 50 0.052
Smokers (%) 39.7 100 0
Clinical measurements
PBS 2.0 – 1.1 2.0 – 1.0 2.0 – 1.2 Not significant
Probing depth (mm) 4.6 – 1.5 4.9 – 1.5 4.3 – 1.5 <0.00
Pockets >3 mm (%) 78 – 41 87 – 33.7 72 – 45 <0.001
Pockets >4 mm (%) 52 – 50 65 – 48 46 – 50 <0.001
Pockets >5 mm (%) 31 – 46 38 – 49 26 – 44 <0.001
Recession (mm) 0.6 – 0.9 0.8 – 0.9 0.5 – 0.8 <0.001
Attachment level (mm) 5.1 – 1.9 5.7 – 1.9 4.8 – 1.8 <0.001
Microbiological tests
BANA positive (%) 28 – 38.4 33 – 40 25.0 – 37 0.001
WBC positive (%) 48.8 – 42.4 53 – 42 46 – 37 0.008
Spirochetes (%) 26.5 – 35.9 35 – 33 21 – 36 <0.001
Small (%) 6.1 – 18.1 9 – 22 4 – 15 <0.001
Large (%) 20.8 – 34 26 – 37 17 – 31 <0.001
Small gliding rods (%) 28 – 35.8 34 – 38 24 – 33 <0.001
Large gliding rods (%) 14 – 26.9 18 – 30 12 – 24 0.004
Spinning rods (%) 41.9 – 39.8 48 – 40 38 – 39 <0.001
Spiral rods (%) 0.9 – 6.7 1.2 – 7 0.8 – 0.6 Not significant
Motile cocci (%) 7.9 – 21.9 9 – 23 7 – 21 Not significant
Protozoans (%) <0.05
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74.6%,andthenegativepredictivevalue(TN/TN+FN)
was 72.9%. However, because of the similarity of
sensitivity, specificity, and positive- and negative-
predictive values, there would be little change in the
number of subjects incorrectly diagnosed if the per-
centage of WBCs was used as the primary reference.
For example, 550 subjects would be recommended
for treatment based on the presence of probing depths
‡5 mm, and 563 subjects would be recommended for
treatmentbasedupon thepresenceof >50%of thesites
being positive for WBCs. About 75% of these would be
the same subject. Among the subjects for whom treat-
ment is not recommended, about 72% would be the
same subject.
The real differences between the two diagnostic cri-
teria would be subjects misclassified as needing or not
needing treatment. The probing depth model would
recommend treatment for 130 subjects who have
pockets ‡5 mm but minimal evidence of inflammatory
disease and would not recommend treatment for 143
subjects who have pockets £4 mm but with more than
50% of sites showing clinical inflammation. The WBC
model would recommend just the opposite, i.e., no
treatment for the 130 subjects with pockets ‡5 mm
but minimal evidence of inflammatory disease and
treatment for the 143 subjects with shallow pockets
but evidence of inflammation.
Patients are usually informed that they have peri-
odontal disease based upon the presence of 5- and
6-mm pockets. This traditional approach has rarely
been validated against the presence of inflammatory
markers or the presence of an infection. As explana-
tory variables for all three diagnostic approaches were
available for the 1,043 patients, multivariate diagnos-
tic models were constructed using probing depths,
inflammatory markers (WBCs), or an anaerobic infec-
tion (BANA scores) as the basis for diagnosing peri-
odontal disease. Explanatory variables described in
Table 1 were entered into these models to determine
which of them would contribute to the diagnosis.
We looked at those probing depth, WBC, and BANA
models that identified about the same number of sub-
jects, i.e., 43% to 54%, as having periodontal disease.
We chose ‡5 mm as the probing depth model, as it re-
flects clinical practice and because it identified 540
subjects as having periodontal disease. The model of
>50% of sites positive for WBCs was chosen because
it identified 563 subjects, and the model of >0% of sites
positive for BANA was chosen because it identified
445 subjects. All models were highly significant (P
<0.0001), but the WBC model was the most parsimo-
nious, i.e., had the lowest Akaike information criteria
(AIC) value, and exhibited the highest ROC curve
(Fig. 1), indicating that it was the best of the three
models. The probing depth model had a higher AIC
valueandlowerROCscores,whereas theBANAmodel
had the highest AIC value and the lowest ROC scores
(Table 5).
Age and smoking status were initially included in all
models because of their accepted role as risk factors
in periodontal disease. Age, although a weak but sig-
nificant predictor of periodontal disease in the probing
depth and BANA models, was not a factor in the WBC
model. Likewise smoking status, although a strong
predictor of periodontal disease in the probing depth
model, was not a significant predictor of diagnosis in
the WBC model, and ‘‘quit smoking’’ was a marginally
significant predictor in the BANA model. In the prob-
ing depth model, the PBS, percentage of BANA-
positive sites, the percentage of WBC-positive sites,
and the percentage of spirochetes were significant
predictors of periodontal disease (Table 5). Of these
variables, subjects with BANA-positive sites were
5.3 times more likely to be diagnosed with periodontal
disease than subjects with no BANA-infected sites.
In the WBC model, the probing depth; PBS; per-
centage of BANA-positive sites; percentage of spiro-
chetes; and two microscopic findings, the percentage
of small gliding rods and the percentage of spinning
rods, were significant predictors of periodontal dis-
ease. Of these variables, the percentage of small glid-
ing rods and percentage of spinning rods had the
highest odds ratios (ORs) at 6.3 and 4.9, respectively.
In the BANA model, the probing depth and percent-
age of WBC-positive sites were strong predictors of
periodontal disease. Subjects infected with a percent-
age of spinning rods were 1.7 times more likely to
have a diagnosis of periodontal disease.
Table 2.




Diagnostic Criteria Threshold % N
Probing depth
Sites ‡4 mm Relaxed 78.1 815
Sites ‡5 mm Standard 52.3 540
Sites ‡6 mm Stringent 30.9 318
Sites in which WBCs
are present
>0% Relaxed 65.2 680
>50% Stringent 54.0 563
Sites in which BANA
test is positive
>0% Relaxed 42.7 445
>50% Stringent 24.2 229
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DISCUSSION
The great advantage of using probing depths as a
means of diagnosing periodontal disease is the speed
of execution and immediacy in interpretation. In the
present investigation, the measurement and record-
ing of probing depths around four representative teeth
took about 1 minute. This was less than the 2 minutes
that it took to obtain the plaque samples used to pre-
pare microscopic slides and the BANA test. Another
3 minutes was used to analyze the samples for the
microscopic count, whereas the BANA reading took
no additional effort and was available for interpreta-
tion 5 minutes later. But if the microscopic counting
was limited to WBCs, then the entire process from
sampling to counting would take about 3 minutes. If
only the BANA test was used, then the processing
would take about 1 to 2 minutes. These consider-
ations would indicate that the time advantage enjoyed
by using probing depths is not so great as to preclude
the use of other diagnostic criteria if these criteria can
be demonstrated to be more accurate in diagnosing
periodontal disease/infections.
The use of probing depths to diagnose periodontal
disease is a surrogate for more meaningful measure-
ments such as bone and attachment loss. As such, it
is a one-dimensional measurement, albeit the most
important dimension, of the volume of the space, or
pocket,overlyinganareaon the rootsurfaceofa tooth,
andhasa largemeasurementerror (–1mm)so that the
measuring error for a 5-mm pocket would be 40%, i.e.,
Table 3.
Chi-Square Comparisons of Relaxed and Stringent Levels of Probing Depths, Percentage
of WBC-Positive Sites, and Percentage of BANA-Positive Sites*
Reference
Probing Depth Test WBC Accuracy (%) FP (%) FN (%) TP (%) TN (%) Cohen
£3 versus ‡4 mm 0% versus >0% 74.6 6.2 19.2 59 15.6 0.39
£4 versus ‡5 mm 0% versus >0% 70.9 20.8 8.3 44 26.5 0.41
£5 versus ‡6 mm 0% versus >0% 60.1 37.1 2.8 28 32 0.29
£3 versus ‡4 mm £50% versus >50% 68 4 28 50 18 0.33
£4 versus ‡5 mm* £50% versus >50% 73.8* 14* 13* 40* 34* 0.47*
£5 versus ‡6 mm £50% versus >50% 68.6 27 4 27 42 0.39
Reference
Probing Depth Test BANA Accuracy (%) FP (%) FN (%) TP (%) TN (%) Cohen
£3 versus ‡4 mm 0% versus >0% 57.6 4 39 39 18 0.22
£4 versus ‡5 mm 0% versus >0% 67.5 11 21 31 36 0.36
£5 versus ‡6 mm 0% versus >0% 66.9 22 11 20 47 0.30
£3 versus ‡4 mm £50% versus >50% 43.3 1 55 23 21 0.12
£4 versus ‡5 mm £50% versus >50% 64 4 32 20 43 0.30
£5 versus ‡6 mm £50% versus >50% 75.5 9 16 15 60 0.39
Reference WBC Test BANA Accuracy (%) FP (%) FN (%) TP (%) TN (%) Cohen
0% versus >0% 0% versus >0% 61.7 8 30 35 27 0.27
0% versus >0% £50% versus >50% 53.8 3 44 22 32 0.20
£50% versus >50% 0% versus >0% 64 12 24 30 34 0.29
£50% versus >50% £50% versus >50% 61.9 4 34 20 42 0.27
All comparisons are significant at P <0.001.
* Best agreement.
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2/5 mm.19 This means that some teeth (subjects) with
no disease/infection may be incorrectly recommen-
ded for treatment, whereas others with disease/infec-
tion would not be recommended for treatment based
on measuring error alone. These considerations indi-
cate that analternatemeansofdiagnosingperiodontal
disease based upon indicators of an inflammatory
process/infection should be pursued.
Probing depth was considered to be the primary
standard in the chi-square (x2) comparisons with
the percentage of sites WBC positive or percentage
of sites BANA positive because it is the de facto clin-
ical standard. At each threshold for probing depths,
the percentage of sites WBC positive or percentage
of sites BANA positive were significantly related to
probing depths (P <0.0001; Table 3) in their ability
to recognize patients with periodontal disease. But
the percentage of accuracy indicated that these diag-
nostic criteria were identifying the same patients in
60% to 75% of the comparisons.
This result was illustrated by analyzing the number
of patients who would be recommended for treatment
when the threshold for probing depths was ‡5 mm and
that for the percentage of WBCs was >50% of sites
(Table 4). This probing depth threshold would have
recommended periodontal treatment for 550 pa-
tients. Seventy-six percent of these patients would
have received the same recommendation if the
threshold of >50% WBCs was used, but the remaining
24%, or 130 patients, who had £50% of sites that were
WBC positive, would also have been recommended
for treatment. If the comparison was between probing
depths ‡5 mm and percentage of WBCs >0%, then 8%
or 87 patients without any evidence of inflammatory
disease would have been recommended for treatment
(calculated from date presented in Table 3). Thus, ap-
preciable numbers of patients without evidence of
inflammatory disease would have been diagnosed
by probing depths as having a disease that is inflam-
matory in nature.
If the roles were reversed, with the threshold of
>50% WBCs used as the primary decision for recom-
mending periodontal treatment, then 563 patients
would have been recommended for treatment,
74.6% of whom would also have been identified by
the probing depth threshold (Table 4). This means that
25.6%, or 143 patients, with probing depths £4 mm,
would have been recommended for treatment be-
cause of the presence of inflammatory markers in the
plaque sample.
These differences in treatment recommendations
raised the question, ‘‘Is it better to treat sites (patients)
with deep pockets without much evidence of inflam-
matory markers or to treat sites (patients) with inflam-
matory markers but without deep pockets? Insights
into this question were sought with multivariate diag-
nostic models.
All diagnostic models were highly significant and
shared certain predictors in common (Table 5). For
instance, probing depth, as an indicator of bacteria
mass, was a significant predictor of periodontal dis-
ease in the WBC and BANA models. The percentage
of WBC-positive sites was an even stronger predictor
of periodontal disease in the probing depth model
(OR = 2.8) and the BANA model (OR = 2.1). The per-
centage of BANA-positive sites was a very strong pre-
dictor in the probing depth model (OR = 5.3) and in the
WBC model (OR = 2.1) The PBS was a strong predic-
tor of periodontal disease in the probing depth model
(OR = 2.6) and the WBC model (OR = 2.2).
The WBC model had an ROC curve of 90%, which is
very high, and was unique in having microbial varia-
bles as important predictors of treatment needs, i.e.,
the percentage of small gliding rods (OR = 6.3), per-
centage of spinning rods (OR = 4.9), and percentage
of spirochetes (OR = 1.9). The identity of the spinning
and gliding rods is not known, but they would be cat-
egorized as motile rods, a group that has repeatedly
been associated with periodontal disease by semi-
quantitative darkfield-microscopy examinations of
plaque samples11,12,20-22 and by qualitative phase-
contrast microscopy.10 The fact that the spinning rods
were also a significant predictor of treatment needs in
the BANA model would suggest that they may be the
single most important bacterial determinant of peri-
odontal disease/infections, and they remained to be
identified at the species level.
Table 4.
Comparison of Probing Depths ‡5 mm and
WBC Levels >50% of Sites as a Guide in













No treatment 350 130 480
>50% sites
positive
Treatment 143 420 563
493 550 1,043
If probing depth is the reference standard, then sensitivity = 76.4%;
specificity = 71%; accuracy = 73.8%; positive predictive value = 74.6%;
negative predictive value = 72.9%; false negative = 130; and false positive =
143. If WBC is the reference standard, then 76.4% = positive predictive
value; 71% = negative predictive value; 73.8% = accuracy; 74.6% =
sensitivity; 72.9% = specificity; 130 = false positive; and 143 = false
negative.
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The probing depth model demonstrated the validity
of the statistical approaches that were used as this
model captured an eclectic mix of demographic, clin-
ical, microscopic, and bacteriological findings that
have been historically associated with periodontal
disease. For example, increasing age had a slight
but significant effect on the diagnosis of periodontal
disease, which is consistent with epidemiological
studies that have associated age with periodontal dis-
ease.23,24 A history of smoking and current smoking
were strong predictors of periodontal disease.25,26
Gingivitis, as measured with the PBS, was also a
strong predictor, which is consistent with many stud-
ies that have emphasized bleeding as a diagnostic in-
dicator of periodontal disease.8,27 The probing depth
model also had strong inflammatory and infection
components, as the percentage of WBC-positive sites,
percentage of BANA-positive
sites, and percentage of
spirochete-positive sites were
strong predictors of treatment
needs. Keyes and Rams10 have
implicated the presence of
WBCs in periodontal disease,
and many studies have linked
spirochetes to periodontal dis-
ease.28,29 The BANA test has
been associated with periodon-
tal disease in epidemiologi-
cal30,31 and clinical studies.32
When the diagnostic model
was based upon the presence
of WBCs, traditional risk deter-
minants, such as age and smok-
ing status, were not significant.
As the pathophysiology in peri-
odontal disease is an inflamma-
tory response to a bacterial
overgrowth of certain bacteria
in the plaque, age, per se, should
have no obvious effect on such
an infection. Smoking has been
shown to be a risk factor when
probing depths have been
used,24 but its role, other than
decreasing the blood flow to
the gingiva,33 has not been elu-
cidated. Several studies have
shown that current smokers
and former smokers have higher
percentages of BANA-positive
plaques34 and higher levels of
BANA-positive species such
as P. gingivalis, T. forsythensis,
and T. denticola in their pla-
ques.35,36 This raises the possi-
bility that the contributions made by the BANA
results and smoking status to the clinical outcome in
the WBC model were so correlated that only one, the
percentage BANA positive sites, emerged as a signifi-
cant predictor for the diagnosis. This suggests that
smoking could have been a surrogate for an infection
due toBANA-positive species in thosestudies that iden-
tified smoking as a risk factor for periodontal disease.
The BANA model showed a modest effect of age
(OR = 1.01) and probing depth (OR = 1.34) but was
more dependent on the percentage of sites positive
for WBC (OR = 2.09) and the percentage of sites pos-
itive for spinning rods (OR = 1.69) as significant pre-
dictors of subjects being diagnosed with periodontal
disease. The absence of spirochetes was unexpected,
as previous studies have implicated spirochetal
counts with a positive BANA test.37
Table 5.
Comparison of Models in Their Ability to Diagnose
Periodontal Disease





AIC statistic 908 826 1226
ROC curve 87.4 90.4 73.7
Predictor P OR P OR P OR
Variable:
Age <0.001 1.03 0.015 1.01
Smoker never
Quit <0.001 2.72 0.068 1.34
Current 0.001 2.36 0.78 0.94
Probing depth NA 0.002 1.3 <0.001 1.34
PBS <0.001 2.56 <0.001 2.23
WBC positive (%) <0.001 2.76 NA 0.001 2.09
BANA positive (%) <0.001 5.26 0.008 2.09 NA
Small gliding rods (%) <0.001 6.27
Spinning rods (%) <0.001 4.91 <0.022 1.69
Spirochetes (%) 0.024 1.90 0.06 1.86
Likelihood ratio 502.7 627.3 164.
Degrees of freedom 7 6 5
All models are significant at P <0.0001. The best score for each test is in bold type.
AIC = -2 log(L) + 2p where L is the likelihood statistics and p is the number of predictors in the model.
A low AIC value is better, which indicates a better fit (high L) with fewer degrees of freedom (low p).
NA = a variable is not applicable in the model under consideration.
ROC = receiver operator curve, where the higher the score, the larger the area under the curve.
J Periodontol • September 2006 Apsey, Kaciroti, Loesche
1579
The detection of WBCs in a plaque sample would
seem to capture the host response to all of the perio-
dontopathogens, such as spinning rods, small gliding
rods, spirochetes, and BANA-positive species, as well
as the bacterial mass reflected by the probing depth
and the bleeding that occurs as the tissue response to
the infection. This superiority of WBCs as a diagnostic
for periodontal disease can be transferred to the clin-
ical setting. With some training, clinicians could con-
fidently use phase-contrast microscopic analysis of
WBC levels in plaque to place their patients into risk
categories of periodontal disease or health. This ap-
proach would change the diagnosis from periodontal
disease to periodontitis and would be in harmony with
the pathophysiology of the disease process. It would
also emphasize the expanding recognition of the con-
tributions of inflammatory diseases, including peri-
odontitis, to systemic health such as cardiovascular
disease and preterm births.38,39
CONCLUSION
These results indicate that periodontal disease can
be diagnosed chairside by the presence of WBCs in
plaque samples, a finding that reflects the inflamma-
tory nature of the disease process.
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